As per our research report, the size of the Middle East & Africa, Pharmaceutical Filtration Market has been calculated at USD 1.20 billion in 2022. It is forecasted to be growing at a CAGR of 8.7% and worth USD 1.81 billion by 2027.
Filtration is a physical technique employed in various fields, including the pharmaceutical industry. It is one of the essential processes adopted in the pharmaceutical industry. The filtration process can also be combined with other operations. It is different from sieving, where separation is carried out using a single perforated layer. It is unlike filtration, where a multi-layer lattice is generally used. This technique is used in many processes such as air filtration, bulk and solvent filtration, and water filtration.
Pharmaceutical filtration is done to limit the presence of bacteria in processed pharmaceutical components which includes drugs, crèmes, and other raw materials, etc. Filtration prevents the treated solution from becoming contaminated and helps maintain sterility. Many chemicals undergo microfiltration for the removal of unwanted suspensions or the removal of bacteria from the processed material. The increase in the development of biopharmaceutical companies and technological advancements in filtration techniques are the main growth factors of the market. The increasing adoption of bio-chemical proteins has demand for higher utilization of protein purification processes such as flow filtration, ultrafiltration, etc.
Some companies are also involved in research and development, to launch new products with accurate efficiency and lesser side effects. Many regions in MEA depend heavily on China and India for importing drugs, which cannot be manufactured locally due to the unavailability of raw materials. This also offers several opportunities for the pharmaceutical industry to grow which in turn is influencing the MEA pharmaceutical filtration market. Strong demand for advanced therapeutic drugs and increasing vaccines owing to the high incidences of various diseases are expected to further improve the overall demand of the Middle East & Africa Pharmaceutical Filtration market during the forecast period 2020-2025.
The Biosciences Unit of the Council for Scientific and Industrial Research is carrying out a large collaborative research project with the help of the latest technology. The project is funded by various public-private foundations in South Africa The increasing incidence of communicable diseases, increased production of drugs, and the rapid expansion biopharmaceutical industry are driving the growth of the MEA pharmaceutical filtration market.
However, The MEA pharmaceutical filtration market faces several restraints in obtaining approvals for new and innovative products owing to stringent rules and the long time required for the production process which are likely to have problems with drug production. The process can run steadily without failure. Poor economical standards are affecting the product manufacturing in the African region, this will negatively influence the overall Middle East & Africa pharmaceutical filtration market during the projected period.
This research report on the Middle East and Africa Pharmaceutical Filtration Market has been segmented and sub-segmented into the following categories:
MCE Membrane Filters
Coated Cellulose Acetate Membrane Filters
Nylon Membrane Filters
PTFE Membrane Filters
PVDF Membrane Filters
Other Membrane Filters
Prefilters And Depth Media Filters
Glass Fiber Filters
PTFE Fiber Filters
Cartridge& Capsule Filters
Final Product Processing
Vaccine and Antibody Processing
Formulation and Filling Solution Filtration
Raw Material Filtration
Media and Buffer Filtration
Prefiltration And Bioburden Testing
rest of GCC countries
rest of MEA
Saudi Arabia dominated the MEA market in 2020 with a share of over 32%, followed by Qatar and then Iran due to the growth of the biopharmaceutical industry. In Saudi Arabia, high healthcare expenditure and advanced medical facilities are the main driving forces behind the market studied. There is a strong growth in the pharmaceutical industry nationwide, which is expected to influence the demand for pharmaceutical filtration products. Hence, the growth of the pharmaceutical industry has the potential to expand the scope and growth of the MEA pharmaceutical filtration market in Saudi Arabia.
Qatar is expected to grow at a higher CAGR of 5.9% during the forecast period 2020-2027 due to advanced healthcare infrastructure and the availability of technologically advanced products. In addition, the high incidence of chronic diseases in the country has resulted in the implementation of pharmaceutical filters, further influencing the progress of the MEA pharmaceutical filtration market in Qatar.
In Iran, the pharmaceutical sector has grown considerably over the past several decades, with companies primarily focused on drug manufacturing. Due to the increase in acute and chronic diseases, the demand for good drugs is increasing in the country. In addition, the government's collaborations and initiatives to improve healthcare measures across the country to reduce death rates and increase life expectancy are driving the future of the Middle East & Africa pharmaceutical filtration market. The increasing prevalence of diseases such as AIDS, Alzheimer's disease, malaria, inflammatory diseases, and other drug-resistant infectious diseases has also led to the discovery of new biological compounds. These factors have drastically boosted the market and are expected to open up new growth opportunities during the forecast period.
KEY MARKET PLAYERS:
Companies playing a leading role in the MEA pharmaceutical filtration market are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org